Pharma Services M&A Valuation Segment Report
Comparable Transactions / Precedent Deals
 
Excel spreadsheet wth Scope Research's pharma services M&A valuation data and benchmarking tools. Transactions involve a mixture of CRO, CDMO, consulting, commercialization, and other pharmaceutical services organizations of different sizes.
 
143 transactions with revenue or EBITDA multiples (since 2010)
116 of these deals have reported EBITDA Multiples
Last updated 12/4/24
 
Each transaction includes price to revenue and/or EBITDA multiples. We provide the names of the parties, transaction date, ownership percentage acquired, deal price (stated on a total enterprise value basis), time period of the financial information relied upon, revenue and/or EBITDA, and a description of our source documents and key details related to the financial information presented. 

Reach out to will@scoperesearch.co for more information.

All transactions included in the Scope Research healthcare M&A databases are meticulously researched and sourced from public documentation. Our internal records include an audit trail of links to our sources, which include:
Fairness opinions
SEC filings
Press releases
Bond market research
Medicare cost reports
CON filings (FOIA)
Form 990s
Public audits
AG reports
Insurance department filings